• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2014 年至 2017 年期间,新加坡一家三级医院中与接受门诊肠外抗生素治疗相关的社会人口学和临床因素。

Sociodemographic and clinical factors associated with acceptance of outpatient parenteral antibiotic therapy in a Singapore tertiary hospital from 2014 to 2017.

机构信息

Adjunct Research Fellow, Duke-NUS Graduate Medical School, Singapore, Singapore.

Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.

出版信息

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):277-284. doi: 10.1007/s10096-018-3424-2. Epub 2018 Nov 14.

DOI:10.1007/s10096-018-3424-2
PMID:30430375
Abstract

Outpatient parenteral antibiotic therapy (OPAT) can facilitate early discharge; however, not all offered OPAT can accept. We assessed factors associated with acceptance of OPAT in a large Asian tertiary hospital cohort. From 2014 to 2017, we reviewed all referrals to Singapore General Hospital's (SGH) Outpatient Parenteral Antibiotic Therapy (OPAT) service. We compared differences in sociodemographic and clinical factors between patients who opted for OPAT and those who declined, using chi-square test for univariate analysis and logistic regression for multivariate analysis. From 2014 to 2017, a total of 1406 OPAT referrals were made. Of these, 95.9% (1349/1406) were deemed suitable for OPAT. Amongst those suitable, 90.0% (1213/1349) accepted OPAT treatment. On multivariate analysis, being independently ambulant (aOR = 3.46, 95%CI = 2.21-5.37) was independently associated with higher odds of acceptance for OPAT; whereas, patients with peripheral vascular disease had lower odds of accepting OPAT (aOR = 0.32, 95%CI = 0.16-0.62). Lower socioeconomic status (SES) was closely associated with rejection of OPAT, with markers of both individual-level SES (subsidized ward class) and area-level SES (staying in a public rental flat) being independently associated with lower odds of OPAT preference. Distance and travel time were not associated with OPAT acceptance. The top reasons for rejecting OPAT were lack of caregiver (n = 35), mobility issues (n = 24), financial issues (n = 24), and difficulty caring for the line (n = 21). Comorbidities, mobility, and financial issues are important factors to consider when determining suitability for OPAT. More can be done to improve accessibility of OPAT amongst lower-income patients and those staying in lower-SES areas.

摘要

门诊静脉抗生素治疗(OPAT)可以促进患者提前出院;然而,并非所有提供的 OPAT 都能被接受。我们评估了在一家大型亚洲三级医院队列中,与接受 OPAT 相关的因素。2014 年至 2017 年,我们回顾了所有转至新加坡中央医院(SGH)门诊静脉抗生素治疗(OPAT)服务的患者。我们比较了选择 OPAT 和拒绝 OPAT 的患者在社会人口统计学和临床因素方面的差异,使用卡方检验进行单因素分析,使用逻辑回归进行多因素分析。2014 年至 2017 年,共进行了 1406 次 OPAT 转介。其中,95.9%(1349/1406)被认为适合 OPAT。在适合的患者中,90.0%(1213/1349)接受了 OPAT 治疗。多因素分析显示,独立行走能力(优势比[OR] = 3.46,95%置信区间[CI] = 2.21-5.37)与接受 OPAT 的可能性更高独立相关;而患有外周血管疾病的患者接受 OPAT 的可能性较低(OR = 0.32,95%CI = 0.16-0.62)。较低的社会经济地位(SES)与拒绝 OPAT 密切相关,个体 SES 标志物(补贴病房类别)和地区 SES 标志物(居住在公共出租公寓)与接受 OPAT 的可能性较低独立相关。距离和旅行时间与 OPAT 接受无关。拒绝 OPAT 的主要原因是缺乏照顾者(n = 35)、行动不便(n = 24)、经济问题(n = 24)和难以护理管道(n = 21)。合并症、行动能力和经济问题是决定 OPAT 适用性的重要因素。可以采取更多措施来提高低收入患者和 SES 较低地区患者接受 OPAT 的机会。

相似文献

1
Sociodemographic and clinical factors associated with acceptance of outpatient parenteral antibiotic therapy in a Singapore tertiary hospital from 2014 to 2017.2014 年至 2017 年期间,新加坡一家三级医院中与接受门诊肠外抗生素治疗相关的社会人口学和临床因素。
Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):277-284. doi: 10.1007/s10096-018-3424-2. Epub 2018 Nov 14.
2
Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.门诊肠外抗菌治疗服务可及性的不公平:关联横断面研究。
Int J Equity Health. 2020 Sep 1;19(1):150. doi: 10.1186/s12939-020-01261-w.
3
Health-related quality of life and its association with outcomes of outpatient parenteral antibiotic therapy.门诊患者接受抗生素治疗的健康相关生活质量及其与结局的相关性。
Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):765-772. doi: 10.1007/s10096-019-03787-6. Epub 2019 Dec 23.
4
Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.门诊胃肠外抗生素治疗在新加坡社区获得性皮肤及软组织感染治疗中的作用
BMC Infect Dis. 2017 Jul 6;17(1):474. doi: 10.1186/s12879-017-2569-4.
5
Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity.亚洲的门诊胃肠外抗生素治疗(OPAT):错失良机。
J Antimicrob Chemother. 2017 Apr 1;72(4):1221-1226. doi: 10.1093/jac/dkw551.
6
Outpatient parenteral antibiotic therapy in Singapore.新加坡的门诊胃肠外抗生素治疗。 (你原文中的“parenteral”疑似有误,正确的可能是“parenteral”,意为“胃肠外的” ,我按照纠正后的意思翻译,若有误请根据实际情况调整 )
Int J Antimicrob Agents. 2006 Dec;28(6):545-50. doi: 10.1016/j.ijantimicag.2006.08.018. Epub 2006 Nov 13.
7
An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort.一项大型亚洲队列中外门诊患者静脉用抗生素治疗(OPAT)的结局分析。
Int J Antimicrob Agents. 2013 Jun;41(6):569-73. doi: 10.1016/j.ijantimicag.2013.01.015. Epub 2013 Feb 28.
8
Clinical and cost-effectiveness, safety and acceptability of ommunity ntraenous ntibiotic ervice models: CIVAS systematic review.社区静脉抗生素服务模式的临床及成本效益、安全性与可接受性:CIVAS系统评价
BMJ Open. 2017 Apr 20;7(4):e013560. doi: 10.1136/bmjopen-2016-013560.
9
The utility of a blood culture database to identify patients suitable for outpatient parenteral antibiotic treatment.血培养数据库用于识别适合门诊胃肠外抗生素治疗患者的效用。
Postgrad Med J. 2017 Jul;93(1101):382-388. doi: 10.1136/postgradmedj-2016-134441. Epub 2016 Nov 7.
10
Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.门诊静脉用抗生素治疗 (OPAT) 的临床疗效、成本分析和患者接受度:谢菲尔德(英国)OPAT 服务十年来的经验。
Int J Antimicrob Agents. 2018 Jan;51(1):26-32. doi: 10.1016/j.ijantimicag.2017.03.016. Epub 2017 Jun 30.

引用本文的文献

1
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.门诊患者的肠外抗菌治疗的现状和挑战:叙事性综述。
J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177.

本文引用的文献

1
Evaluation of Medicare's Bundled Payments Initiative for Medical Conditions.医疗保险捆绑支付计划对医疗状况的评估。
N Engl J Med. 2018 Jul 19;379(3):260-269. doi: 10.1056/NEJMsa1801569.
2
A systematic review of health status, health seeking behaviour and healthcare utilisation of low socioeconomic status populations in urban Singapore.新加坡城市中社会经济地位较低人群的健康状况、寻医行为和医疗保健利用的系统评价
Int J Equity Health. 2018 Apr 2;17(1):39. doi: 10.1186/s12939-018-0751-y.
3
Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on All-Cause 30-Day Hospital Readmissions.
布朗克斯区的综合措施:门诊肠外抗生素治疗综合措施对全因30天再入院率的影响。
Open Forum Infect Dis. 2017 Jun 29;4(2):ofx097. doi: 10.1093/ofid/ofx097. eCollection 2017 Spring.
4
Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review.门诊胃肠外抗菌治疗的经济学评估:一项系统综述。
Expert Rev Pharmacoecon Outcomes Res. 2017 Aug;17(4):355-375. doi: 10.1080/14737167.2017.1360767. Epub 2017 Aug 4.
5
Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.门诊胃肠外抗生素治疗在新加坡社区获得性皮肤及软组织感染治疗中的作用
BMC Infect Dis. 2017 Jul 6;17(1):474. doi: 10.1186/s12879-017-2569-4.
6
Clinical and cost-effectiveness, safety and acceptability of ommunity ntraenous ntibiotic ervice models: CIVAS systematic review.社区静脉抗生素服务模式的临床及成本效益、安全性与可接受性:CIVAS系统评价
BMJ Open. 2017 Apr 20;7(4):e013560. doi: 10.1136/bmjopen-2016-013560.
7
Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity.亚洲的门诊胃肠外抗生素治疗(OPAT):错失良机。
J Antimicrob Chemother. 2017 Apr 1;72(4):1221-1226. doi: 10.1093/jac/dkw551.
8
Applying the Integrated Practice Unit Concept to a Modified Virtual Ward Model of Care for Patients at Highest Risk of Readmission: A Randomized Controlled Trial.将综合实践单元概念应用于针对再入院风险最高患者的改良虚拟病房护理模式:一项随机对照试验。
PLoS One. 2017 Jan 3;12(1):e0168757. doi: 10.1371/journal.pone.0168757. eCollection 2017.
9
Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections.厄他培南用于复杂性尿路感染的门诊胃肠外抗菌治疗
J Chemother. 2017 Feb;29(1):25-29. doi: 10.1080/1120009X.2016.1158937. Epub 2016 May 30.
10
The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.门诊胃肠外抗菌治疗的使用、合理性及结果。
Arch Dis Child. 2016 Oct;101(10):886-93. doi: 10.1136/archdischild-2015-309731. Epub 2016 May 10.